Isomorphic Labs applies AI to drug discovery, building on the protein-structure work of AlphaFold to model biology and design new medicines computationally.
Founded in 2021 as an Alphabet company spun out of Google DeepMind, it partners with pharmaceutical companies on small-molecule programmes.
